Possible contribution of aminopeptidase N (APN/CD13) to invasive potentialenhanced by interleukin-6 and soluble interleukin-6 receptor in human osteosarcoma cell lines
A. Kido et al., Possible contribution of aminopeptidase N (APN/CD13) to invasive potentialenhanced by interleukin-6 and soluble interleukin-6 receptor in human osteosarcoma cell lines, CLIN EXP M, 17(10), 1999, pp. 857-863
This study aimed at clarifying the role of Aminopeptidase N (APN), a Zn2+-d
ependent ectopeptidase localized on the cell surface of human osteosarcoma
cell lines treated with proinflammatory cytokines. We investigated the proi
nflammatory cytokines interleukin-1 beta (IL-1 beta), IL-6 and tumor necros
is factor alpha (TNF-alpha) as well as the anti-inflammatory cytokine trans
forming growth factor beta (TGF-beta) for their influence on APN regulation
. Soluble IL-6 receptor (sIL-6R) was always used together with IL-6 to achi
eve a stable effect. In addition, the invasive potential of the osteosarcom
a cell lines MG63 and HOS was examined. Competitive RT-PCR and Ala-pNA acti
vity assays revealed that IL-6 and sIL-6R significantly increased the mRNA
expression and activity of APN in both osteosarcoma cell lines. Although IL
-1 beta significantly stimulated APN mRNA expression in both cell lines, it
influenced the enzyme activity only in MG63. TNF-alpha and TGF-beta, howev
er, had an effect neither on mRNA expression nor on the enzyme activity of
APN in both cell lines. In the Matrigel invasion assay, IL-6 and sIL-6R sig
nificantly up-regulated the transmigration of these cell lines, whereas oth
er cytokines did not. The up-regulated invasion was inhibited by bestatin,
a specific inhibitor of APN. Cellular migration correlated highly with APN
activity (r=0.79, P < 0.002). These findings suggest that APN contributes t
o the invasive potential of human osteosarcomas enhanced by IL-6 and SIL-6R
.